ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $533,000 | +393.5% | 9,265 | +446.0% | 0.05% | +261.5% |
| Q1 2015 | $108,000 | +38.5% | 1,697 | +34.4% | 0.01% | +62.5% |
| Q4 2014 | $78,000 | -36.1% | 1,263 | -59.8% | 0.01% | -42.9% |
| Q3 2014 | $122,000 | +12100.0% | 3,138 | +20820.0% | 0.01% | – |
| Q2 2014 | $1,000 | -98.9% | 15 | -99.3% | 0.00% | -100.0% |
| Q1 2014 | $95,000 | +82.7% | 2,197 | +67.2% | 0.01% | +33.3% |
| Q4 2013 | $52,000 | -84.4% | 1,314 | -85.2% | 0.01% | -75.0% |
| Q3 2013 | $334,000 | +255.3% | 8,890 | +153.9% | 0.04% | +350.0% |
| Q2 2013 | $94,000 | – | 3,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |